Over the last 50 years, the spectrum of clinical presenta- tion of primary hyperparathyroidism (PHPT) has shifted from a symptomatic disorder, characterized by symptoms of hypercalcemia, nephrolithiasis, and overt bone disease, toward a less symptomatic or asymptomatic disorder . The recognition of the asymptomatic variant of PHPT has markedly increased following the inclusion of serum calcium measurement in the multichannel biochemical screening
Italian Society of Endocrinology Consensus Statement: Definition, evaluation and management of patients with mild primary hyperparathyroidism / Marcocci, C; Brandi, M. L.; Scillitani, A.; Corbetta, S.; Faggiano, A.; Gianotti, L.; Migliaccio, S.; Minisola, Salvatore. - In: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. - ISSN 0391-4097. - 38:5(2015), pp. 577-593. [10.1007/s40618-015-0261-3]
Italian Society of Endocrinology Consensus Statement: Definition, evaluation and management of patients with mild primary hyperparathyroidism
Faggiano, A.;Migliaccio, S.;MINISOLA, Salvatore
2015
Abstract
Over the last 50 years, the spectrum of clinical presenta- tion of primary hyperparathyroidism (PHPT) has shifted from a symptomatic disorder, characterized by symptoms of hypercalcemia, nephrolithiasis, and overt bone disease, toward a less symptomatic or asymptomatic disorder . The recognition of the asymptomatic variant of PHPT has markedly increased following the inclusion of serum calcium measurement in the multichannel biochemical screeningFile | Dimensione | Formato | |
---|---|---|---|
Marcocci_Italian Society of Endocrinology Consensus Statement_2015.pdf
solo utenti autorizzati
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
402 kB
Formato
Adobe PDF
|
402 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.